These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


179 related items for PubMed ID: 7567135

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Differences in cell proliferation and prognostic significance of proliferating cell nuclear antigen and Ki-67 antigen immunoreactivity in in situ and invasive carcinomas of the extrahepatic biliary tract.
    Lee CS.
    Cancer; 1996 Nov 01; 78(9):1881-7. PubMed ID: 8909306
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Carcinomas of the pancreas, gallbladder, extrahepatic bile ducts, and ampulla of vater share a field for carcinogenesis: a population-based study.
    Henson DE, Schwartz AM, Nsouli H, Albores-Saavedra J.
    Arch Pathol Lab Med; 2009 Jan 01; 133(1):67-71. PubMed ID: 19123739
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Transforming growth factor alpha immunoreactivity in human gallbladder and extrahepatic biliary tract tumours.
    Lee CS.
    Eur J Surg Oncol; 1998 Feb 01; 24(1):38-42. PubMed ID: 9542514
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Neoplasms of the ampulla of vater with concurrent pancreatic intraductal neoplasia: a histological and molecular study.
    Agoff SN, Crispin DA, Bronner MP, Dail DH, Hawes SE, Haggitt RC.
    Mod Pathol; 2001 Mar 01; 14(3):139-46. PubMed ID: 11266517
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. p53 protein expression in extrahepatic bile duct cancer.
    Lee YC, Song SY, Chung JB, Kang JK, Park IS.
    Yonsei Med J; 1996 Apr 01; 37(2):112-7. PubMed ID: 8711933
    [Abstract] [Full Text] [Related]

  • 15. Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma.
    Takada T, Amano H, Yasuda H, Nimura Y, Matsushiro T, Kato H, Nagakawa T, Nakayama T, Study Group of Surgical Adjuvant Therapy for Carcinomas of the Pancreas and Biliary Tract.
    Cancer; 2002 Oct 15; 95(8):1685-95. PubMed ID: 12365016
    [Abstract] [Full Text] [Related]

  • 16. Expression of p53 in adenocarcinoma of the gallbladder and bile ducts.
    Washington K, Gottfried MR.
    Liver; 1996 Apr 15; 16(2):99-104. PubMed ID: 8740842
    [Abstract] [Full Text] [Related]

  • 17. Endoscopic ultrasonography assessment in preoperative staging for carcinoma of ampulla of Vater and extrahepatic bile duct.
    Zhang Q, Nian W, Zhang L, Liang J.
    Chin Med J (Engl); 1996 Aug 15; 109(8):622-5. PubMed ID: 9206064
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Prognostic significance of Ki-67 and p53 antigen expression in carcinomas of bile duct and gallbladder.
    Shrestha ML, Miyake H, Kikutsuji T, Tashiro S.
    J Med Invest; 1998 Aug 15; 45(1-4):95-102. PubMed ID: 9864969
    [Abstract] [Full Text] [Related]

  • 20. Time to move to targeted drugs in biliary tract cancer?
    Louvet C, Tournigand C.
    Onkologie; 2010 Aug 15; 33(1-2):10-1. PubMed ID: 20164655
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.